ELISA pro-MMP-9 sandwich kit (mouse): quantitative assay of Ms proMMP-9 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms proMMP-9.
ELISA pro-MMP-9 sandwich kit (mouse): quantitative assay of Ms proMMP-9 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms proMMP-9.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
MMP9 (Matricial Metallopeptidase 9, GELB, CLG4B) is a matrix metalloproteinase, a zinc- and calcium-dependent d ́endopeptidases family that degrades extracellular matrix proteins. MMP9 is secreted as a 92 kDa zymogen and the cleavage of pro-MMP9 results in an active enzyme with a molecular weight of 82 kDa. MMP9 has a gelatin binding domain consisting of three type II fibronectin units, a catalytic domain containing the zinc binding site, a proline-rich type V collagen homologous domain and a similar domain to l'hemopexin. MMP9 is produced by monocytes, macrophages, neutrophils, keratinocytes, fibroblasts, osteoclasts and endothelial cells, and is involved in inflammatory responses, tissue remodeling, wound healing, tumour growth, and metastases. MMP9 is provided by cells derived from the bone marrow and contributes to skin carcinogens. In addition, MMP9 degrades collagens of type IV and V. Studies in rhesus monkeys suggest that the enzyme is involved in l-IL-8-induced mobilization of bone marrow hematopoietic stem cells, and studies in murine models suggest a role in remodeling tumour-associated tissues. Studies have shown that high MMP9 levels are associated with progression of idiopathic atrial fibrillation and aortic aneurysm.
Sensitivity
Sensitivity of the dosage: 50 pg/ml.
Measurement range
Dose range: 74.07-18.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15475313 |
| Specifications |
| Accession number | P41245 |
| Dose range | 74.07-18.000 pg/ml |
| Sensitivity of the dosage | 50 pg/ml |
| Calibration range | 50 pg/ml to 18000 pg/ml |
| Description | Kit ELISA Pro-MMP-9, 96 dosages, 1 kit, mouse species, Streptavidine-HRP conjugate, colorimetric detection method, bound enzyme immunoadsorption assay designed for the quantification and detection of pro-MMP-9 samples using a microplate reader |
| Detectable substances to be analysed | Pro-MMP-9 |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Method of detection | Colorimetric |
| Product type | Kit ELISA |
| Protein family | Proteases, peptidases & inhibitors |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: mouse CD30, mouse L CD30, CD40, CRG-2, CTACK, CXCL16, eotaxin, eotaxin-2, Ligand Fas, fractalkin, GCSF, GM-CFS, IFN-gamma, IGFBP-3, IGFBP-5, IGFBP-6, IL-1 alpha, IL-1 beta, IL-2 |
| Sufficient for | 96 dosages |
| Target species | Mouse |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 17395 |
| Gene symbol(s) | AW743869,B/MMP9,Clg4b,Gel B,MMP-9,pro-MMP-9 |
| Host species | Mouse |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Stalcon, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, 96-well pre-loaded mouse anti-pro-MMP-9 strip plate, recombinan pro-MMP-9 standard |
| Marker or dye | HRP |
| Quantity | 1Â kit |
| Regulatory status | RUO |
| Research disciplines | Bone research |
| Synonym | RP23-61O3.10-001, AW743869, B/MMP9, Clg4b, MMP-9, pro-MMP-9 |
| Target | Mouse |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 2 μl; serum, 2 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EMMMP9 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.